Boxer Capital, LLC - 22 Nov 2021 Form 4 Insider Report for Odonate Therapeutics, Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
24 Nov 2021, 17:00:33 UTC
Prior SEC filing
19 Nov 2021
Next SEC filing
21 Dec 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Boxer Capital, LLC, By:/s/ Aaron Davis, Aaron Davis, Chief Executive Officer

Key filing fact

Boxer Capital, LLC filed Form 4 for Odonate Therapeutics, Inc. on 24 Nov 2021.

Key facts

  • This page summarizes Boxer Capital, LLC's Form 4 filing for Odonate Therapeutics, Inc..
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 24 Nov 2021, 17:00.

Change

  • Previous filing in this sequence was filed on 19 Nov 2021.
  • Current net transaction value: -$623,340.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ODT transaction

Common Stock

Sale

Transaction value
$309,660
Shares
-200,000
Change %
-4.3%
Price
$1.55
Shares after
4,407,086
Date
22 Nov 2021
Ownership
Direct
Footnotes
F1, F2, F3
ODT transaction

Common Stock

Sale

Transaction value
$313,680
Shares
-200,000
Change %
-4.5%
Price
$1.57
Shares after
4,207,086
Date
24 Nov 2021
Ownership
Direct
Footnotes
F1, F2, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. ("Boxer Management"), (iii) Aaron I. Davis, and (iv) Joseph C. Lewis (collectively, the "Boxer Group"). Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.

Footnote F2

These securities are owned indirectly by Boxer Management and Joseph C. Lewis, by virtue of their ownership of Boxer Capital.

Footnote F3

Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $1.5362 to $1.5985.

Footnote F4

Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $1.5479 to $1.5878.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .